Kymera Therapeutics, Inc. Share Price
KYMRKymera Therapeutics, Inc. Stock Performance
Open $86.86 | Prev. Close $87.53 | Circuit Range N/A |
Day Range $85.68 - $86.86 | Year Range $20.25 - $102.81 | Volume 12,302 |
Average Traded $86.08 |
Kymera Therapeutics, Inc. Share Price Chart
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Kymera Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $87.56 | $87.09 | +2.25% |
07-Apr-26 | $83.25 | $85.17 | -0.13% |
06-Apr-26 | $85.14 | $85.29 | +0.09% |
02-Apr-26 | $83.35 | $85.22 | +0.32% |
01-Apr-26 | $84.45 | $84.94 | +1.96% |
31-Mar-26 | $82.95 | $83.31 | +4.77% |
30-Mar-26 | $78.71 | $79.51 | +1.66% |
FAQs on Kymera Therapeutics, Inc. Share Price
Can I buy Kymera Therapeutics, Inc. shares in India?
What is the share price of Kymera Therapeutics, Inc.?
What is the 5 year returns of Kymera Therapeutics, Inc.?
What are the high & low stock price of Kymera Therapeutics, Inc. today?
What is the 52-week high and low of Kymera Therapeutics, Inc. stock?